We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+23.6%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$468M
AUM Growth
+$121M
Cap. Flow
+$48M
Cap. Flow %
10.24%
Top 10 Hldgs %
32.14%
Holding
164
New
62
Increased
72
Reduced
21
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Healthcare 12.52%
3 Consumer Staples 10.71%
4 Communication Services 9.23%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYZ
101
Block Inc
XYZ
$48.4B
$310K 0.07%
+2,950
New +$226K
MED icon
102
Medifast
MED
$109M
$307K 0.07%
+2,213
New +$203K
VEEV icon
103
Veeva Systems
VEEV
$33.1B
$306K 0.07%
+1,307
New +$259K
CRSP icon
104
CRISPR Therapeutics
CRSP
$4.73B
$304K 0.06%
+4,143
New +$242K
LULU icon
105
lululemon athletica
LULU
$13.5B
$303K 0.06%
+970
New +$248K
SNAP icon
106
Snap
SNAP
$7.89B
$303K 0.06%
12,894
+2,747
+27% +$48.9K
ITOT icon
107
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$302K 0.06%
4,347
OC icon
108
Owens Corning
OC
$11.2B
$300K 0.06%
+5,378
New +$251K
NEWR
109
DELISTED
New Relic, Inc.
NEWR
$297K 0.06%
+4,317
New +$258K
TNDM icon
110
Tandem Diabetes Care
TNDM
$1.34B
$288K 0.06%
+2,914
New +$233K
EVBG
111
DELISTED
Everbridge, Inc. Common Stock
EVBG
$284K 0.06%
+2,054
New +$267K
ALNY icon
112
Alnylam Pharmaceuticals
ALNY
$27.5B
$282K 0.06%
+1,906
New +$257K
SRPT icon
113
Sarepta Therapeutics
SRPT
$1.57B
$282K 0.06%
+1,758
New +$239K
IRTC icon
114
iRhythm Holdings
IRTC
$3.85B
$279K 0.06%
+2,408
New +$265K
AYX
115
DELISTED
Alteryx Inc
AYX
$279K 0.06%
+1,696
New +$220K
CLDR
116
DELISTED
Cloudera, Inc.
CLDR
$278K 0.06%
21,886
+4,687
+27% +$45K
CORT icon
117
Corcept Therapeutics
CORT
$12.4B
$275K 0.06%
16,337
+3,219
+25% +$45.2K
BL icon
118
BlackLine
BL
$1.84B
$271K 0.06%
+3,267
New +$218K
HUBS icon
119
HubSpot
HUBS
$12.2B
$271K 0.06%
+1,207
New +$217K
RGEN icon
120
Repligen
RGEN
$7.96B
$270K 0.06%
+2,182
New +$257K
EDIT icon
121
Editas Medicine
EDIT
$396M
$265K 0.06%
+8,955
New +$234K
EPAM icon
122
EPAM Systems
EPAM
$5.51B
$263K 0.06%
+1,044
New +$230K
EXEL icon
123
Exelixis
EXEL
$13.3B
$257K 0.05%
+10,844
New +$251K
PCTY icon
124
Paylocity
PCTY
$7.38B
$257K 0.05%
+1,763
New +$205K
VAW icon
125
Vanguard Materials ETF
VAW
$2.95B
$257K 0.05%
2,129
-698
-25% -$78.5K

Similar funds

Spearhead Capital Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Spearhead Capital Advisors held 164 positions worth $468M, up 35% from $347M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Spearhead Capital Advisors deployed $48M of net new capital in Q2 2020, opening 62 new positions and adding to 72 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 2,616 shares worth $343K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Vanguard Industrials ETF, an estimated $1.52M trimmed.

  • Spearhead Capital Advisors's largest Q2 2020 buy was iShares MSCI USA Momentum Factor ETF: 2,616 shares worth $343K.
  • Spearhead Capital Advisors added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $13.7M increase.
  • Spearhead Capital Advisors's biggest Q2 2020 reduction was Vanguard Industrials ETF, cutting an estimated $1.52M.
  • Spearhead Capital Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2020, selling an estimated $10.9M.
  • Spearhead Capital Advisors's ten largest holdings make up 32% of its $468M portfolio in Q2 2020.
  • Spearhead Capital Advisors opened 62 new positions and closed 6 in Q2 2020.
  • Spearhead Capital Advisors's portfolio value rose 35% quarter-over-quarter to $468M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.